S 033188

Drug Profile

S 033188

Alternative Names: [14C]-S-033188; RG 6152; S-033188

Latest Information Update: 03 Jul 2017

Price : $50

At a glance

  • Originator Shionogi
  • Class Antivirals; Small molecules
  • Mechanism of Action Endonuclease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Influenza virus infections
  • Preclinical Influenza A virus H5N1 subtype

Most Recent Events

  • 29 Apr 2017 Pharmacodynamics data from a preclinical study in Influenza virus infections presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID-2017)
  • 25 Apr 2017 Pharmacodynamics data from a preclinical study in Influenza virus infections presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID-2017)
  • 24 Apr 2017 Pharmacodynamics data from a preclinical trial in Influenza-A virus H5N1 subtype released by Shionogi
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top